407 related articles for article (PubMed ID: 36560713)
1. Co-Infection of the Epstein-Barr Virus and the Kaposi Sarcoma-Associated Herpesvirus.
Böni M; Rieble L; Münz C
Viruses; 2022 Dec; 14(12):. PubMed ID: 36560713
[TBL] [Abstract][Full Text] [Related]
2. Persistent KSHV Infection Increases EBV-Associated Tumor Formation In Vivo via Enhanced EBV Lytic Gene Expression.
McHugh D; Caduff N; Barros MHM; Rämer PC; Raykova A; Murer A; Landtwing V; Quast I; Styles CT; Spohn M; Fowotade A; Delecluse HJ; Papoudou-Bai A; Lee YM; Kim JM; Middeldorp J; Schulz TF; Cesarman E; Zbinden A; Capaul R; White RE; Allday MJ; Niedobitek G; Blackbourn DJ; Grundhoff A; Münz C
Cell Host Microbe; 2017 Jul; 22(1):61-73.e7. PubMed ID: 28704654
[TBL] [Abstract][Full Text] [Related]
3. [EBV/KSHV co-infection: an effective partnership].
Gruffat H; Manet E
Med Sci (Paris); 2018 Jan; 34(1):79-82. PubMed ID: 29384100
[TBL] [Abstract][Full Text] [Related]
4. Co-infection and co-localization of Kaposi sarcoma-associated herpesvirus and Epstein-Barr virus in HIV-associated Kaposi sarcoma: a case report.
Julius P; Kang G; Siyumbwa S; Musumali J; Tso FY; Ngalamika O; Kaile T; Maate F; Moonga P; West JT; Angeletti P; Wood C
Front Cell Infect Microbiol; 2023; 13():1270935. PubMed ID: 37928187
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus enhances genome maintenance of Kaposi sarcoma-associated herpesvirus.
Bigi R; Landis JT; An H; Caro-Vegas C; Raab-Traub N; Dittmer DP
Proc Natl Acad Sci U S A; 2018 Nov; 115(48):E11379-E11387. PubMed ID: 30429324
[TBL] [Abstract][Full Text] [Related]
6. Natural killer cell responses to human oncogenic γ-herpesvirus infections.
Münz C
Semin Immunol; 2022 Mar; 60():101652. PubMed ID: 36162228
[TBL] [Abstract][Full Text] [Related]
7. Cancers associated with human gammaherpesviruses.
Wen KW; Wang L; Menke JR; Damania B
FEBS J; 2022 Dec; 289(24):7631-7669. PubMed ID: 34536980
[TBL] [Abstract][Full Text] [Related]
8. Immune checkpoints in T cells during oncogenic γ-herpesvirus infections.
Münz C
J Med Virol; 2023 Jan; 95(1):e27840. PubMed ID: 35524342
[TBL] [Abstract][Full Text] [Related]
9. Infection and immune control of human oncogenic γ-herpesviruses in humanized mice.
McHugh D; Caduff N; Murer A; Engelmann C; Deng Y; Zdimerova H; Zens K; Chijioke O; Münz C
Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1773):20180296. PubMed ID: 30955487
[TBL] [Abstract][Full Text] [Related]
10. KSHV infection drives poorly cytotoxic CD56-negative natural killer cell differentiation in vivo upon KSHV/EBV dual infection.
Caduff N; McHugh D; Rieble L; Forconi CS; Ong'echa JM; Oluoch PO; Raykova A; Murer A; Böni M; Zuppiger L; Schulz TF; Blackbourn DJ; Chijioke O; Moormann AM; Münz C
Cell Rep; 2021 May; 35(5):109056. PubMed ID: 33951431
[TBL] [Abstract][Full Text] [Related]
11. Multiple viral infections in primary effusion lymphoma: a model of viral cooperation in lymphomagenesis.
Gloghini A; Volpi CC; Gualeni AV; Dolcetti R; Bongarzone I; De Paoli P; Carbone A
Expert Rev Hematol; 2017 Jun; 10(6):505-514. PubMed ID: 28468596
[TBL] [Abstract][Full Text] [Related]
12. Kaposi sarcoma-associated herpesvirus (human herpesvirus type 8)-associated extracavitary lymphoma: Report of a case in an HIV-positive patient with simultaneous kaposi sarcoma and a review of the literature.
Zhang H; Yang XY; Hong T; Feldman T; Bhattacharyya PK
Acta Haematol; 2010; 123(4):237-41. PubMed ID: 20484888
[TBL] [Abstract][Full Text] [Related]
13. KSHV infection of B cells primes protective T cell responses in humanized mice.
Caduff N; Rieble L; Böni M; McHugh D; Roshan R; Miley W; Labo N; Barman S; Trivett M; Bosma DMT; Rühl J; Goebels N; Whitby D; Münz C
Nat Commun; 2024 Jun; 15(1):4841. PubMed ID: 38844783
[TBL] [Abstract][Full Text] [Related]
14. Modification of EBV Associated Lymphomagenesis and Its Immune Control by Co-Infections and Genetics in Humanized Mice.
Schuhmachers P; Münz C
Front Immunol; 2021; 12():640918. PubMed ID: 33833760
[TBL] [Abstract][Full Text] [Related]
15. Immunodeficiencies that predispose to pathologies by human oncogenic γ-herpesviruses.
Damania B; Münz C
FEMS Microbiol Rev; 2019 Mar; 43(2):181-192. PubMed ID: 30649299
[TBL] [Abstract][Full Text] [Related]
16. The Role of Lytic Infection for Lymphomagenesis of Human γ-Herpesviruses.
Münz C
Front Cell Infect Microbiol; 2021; 11():605258. PubMed ID: 33842383
[TBL] [Abstract][Full Text] [Related]
17. AIDS-Associated Malignancies.
Vangipuram R; Tyring SK
Cancer Treat Res; 2019; 177():1-21. PubMed ID: 30523619
[TBL] [Abstract][Full Text] [Related]
18. Mutual inhibition between Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus lytic replication initiators in dually-infected primary effusion lymphoma.
Jiang Y; Xu D; Zhao Y; Zhang L
PLoS One; 2008 Feb; 3(2):e1569. PubMed ID: 18253508
[TBL] [Abstract][Full Text] [Related]
19. Probing Reconstituted Human Immune Systems in Mice With Oncogenic γ-Herpesvirus Infections.
Münz C
Front Immunol; 2020; 11():581419. PubMed ID: 33013936
[TBL] [Abstract][Full Text] [Related]
20. Double the Trouble When Herpesviruses Join Hands.
Choi UY; Park A; Jung JU
Cell Host Microbe; 2017 Jul; 22(1):5-7. PubMed ID: 28704653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
